For decades, the optimal management of men with prostate cancer has divided the international urological community. Prostate cancer remains the most expensive cancer in the New Zealand healthcare system, the most commonly diagnosed with around 4,000 new cases per year, and a common cause of death.
The Cannabis Referendum provides an opportunity for New Zealand to take another step towards the wider goal of minimising the harms of drug use in this country. Here we summarise why evidence and public health considerations support a yes vote in the Referendum.
The COVID-19 virus was first detected in New Zealand in late February 2020, and by the third week in March, cases were starting to increase rapidly.
As with other countries, New Zealand is facing an ageing population, increasing prevalence of chronic conditions, and persisting health inequalities.
Globally, approximately 300,000 children are diagnosed with cancer each year, a disease which historically had high mortality rates.
Health professionals have the potential to play a central role in receiving disclosures and providing care for physical or emotional trauma relating to sexual assault.
Prostate cancer (PCa) is the most commonly diagnosed cancer for men in numerous developed countries.
Natural cannabis is one of the most widely used recreational drugs in the world. The active constituent, trans-Δ9-tetrahydrocannabinol (THC), is one of approximately 64 different cannabinoids found within the cannabis plant (Cannabis sativa).
Carvedilol, a dual alpha and beta receptor blocker, is a treatment choice in heart failure with reduced ejection fraction with proven mortality benefit.
We describe a case of life-threatening oesophageal rupture where the patient presented with features of an upper gastrointestinal bleed.
We hope that hospice/palliative care (H/PC) organisations will take a fresh look at their current stance against medical assistance in dying (MAID). The present approach will disadvantage some patients in a number of ways.
I am a retired GP, and I will be voting a resounding YES in the EOLC Act Referendum.
There has been extensive debate about whether vaping products such as electronic cigarettes (ECs) will reduce smoking prevalence, and over what kind of regulatory framework would best promote such an outcome.
MR. L. M. Isitt, M.P., is angry at the comments made in the last number of this Journal on his statements in Parliament in the debate on the Masseurs Registration Bill, and writes to the Editor in terms so undignified, unrestrained, and intemperate that his letter is quite unsuited to the pages of this Journal.